MX2011007462A - Composiciones que contienen acido hialuronico para el tratamiento de heridas, cicatrices, formacion de dahesiones postquirurgicas. - Google Patents

Composiciones que contienen acido hialuronico para el tratamiento de heridas, cicatrices, formacion de dahesiones postquirurgicas.

Info

Publication number
MX2011007462A
MX2011007462A MX2011007462A MX2011007462A MX2011007462A MX 2011007462 A MX2011007462 A MX 2011007462A MX 2011007462 A MX2011007462 A MX 2011007462A MX 2011007462 A MX2011007462 A MX 2011007462A MX 2011007462 A MX2011007462 A MX 2011007462A
Authority
MX
Mexico
Prior art keywords
scars
wounds
treatment
post
acid containing
Prior art date
Application number
MX2011007462A
Other languages
English (en)
Inventor
Margit Mahlapuu
Mattias Muennich
Veronika Sjoestrand
Original Assignee
Pharmasurgics In Sweden Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmasurgics In Sweden Ab filed Critical Pharmasurgics In Sweden Ab
Publication of MX2011007462A publication Critical patent/MX2011007462A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40Transferrins, e.g. lactoferrins, ovotransferrins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728Hyaluronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10Peptides having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23Carbohydrates
    • A61L2300/232Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Zoology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a composiciones farmacéuticas que mejoran el efecto terapéutico de péptidos biológicamente activos, en especial péptidos derivados de lactoferrina humana; las composiciones son útiles para el tratamiento y/o prevención de heridas, cicatrices y adhesiones postquirúrgicas.
MX2011007462A 2009-01-13 2010-01-12 Composiciones que contienen acido hialuronico para el tratamiento de heridas, cicatrices, formacion de dahesiones postquirurgicas. MX2011007462A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0900031 2009-01-13
PCT/EP2010/050284 WO2010081800A2 (en) 2009-01-13 2010-01-12 New pharmaceutical compositions

Publications (1)

Publication Number Publication Date
MX2011007462A true MX2011007462A (es) 2011-08-03

Family

ID=42340142

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011007462A MX2011007462A (es) 2009-01-13 2010-01-12 Composiciones que contienen acido hialuronico para el tratamiento de heridas, cicatrices, formacion de dahesiones postquirurgicas.

Country Status (15)

Country Link
US (4) US20110306565A1 (es)
EP (1) EP2387390B1 (es)
JP (1) JP5646507B2 (es)
KR (1) KR101406743B1 (es)
CN (1) CN102271658B (es)
AU (1) AU2010205751B2 (es)
BR (1) BRPI1006076B8 (es)
CA (1) CA2748860C (es)
ES (1) ES2400466T3 (es)
HK (1) HK1164701A1 (es)
MX (1) MX2011007462A (es)
PL (1) PL2387390T3 (es)
RU (1) RU2501566C2 (es)
WO (1) WO2010081800A2 (es)
ZA (1) ZA201105806B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2501566C2 (ru) 2009-01-13 2013-12-20 Пергамум АБ Новые фармацевтические композиции
CN103189078A (zh) * 2010-10-29 2013-07-03 汇美迪斯有限公司 含有透明质酸和l-精氨酸的抗粘连剂
EP2481751A1 (en) 2011-01-26 2012-08-01 PharmaSurgics in Sweden AB Human lactoferrin derived peptides
WO2012154738A1 (en) 2011-05-09 2012-11-15 The Cleveland Clinic Foundation Composition and method to improve intestinal health
FR3002452B1 (fr) * 2013-02-28 2016-02-12 Dermaconcept Jmc Composition dermatologique antimicrobienne topique
CN111281978A (zh) * 2019-08-19 2020-06-16 上海交通大学医学院附属第九人民医院 透明质酸基载体及其制备方法在抗瘢痕中的应用

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141973A (en) 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
US5080893A (en) 1988-05-31 1992-01-14 University Of Florida Method for preventing surgical adhesions using a dilute solution of polymer
SE8900586L (sv) 1989-02-21 1990-08-22 Pharmacia Ab Komposition och foerfarande foer att foerhindra adhesion mellan kroppsvaevnader
JP2818056B2 (ja) * 1990-09-07 1998-10-30 森永乳業株式会社 抗菌性ペプチドおよび抗菌剤
IT1263394B (it) * 1993-07-30 1996-08-05 Fidia Advanced Biopolymers Srl Composizioni farmaceutiche per uso topico a base di acido ialuronico e suoi derivati
JPH0881387A (ja) * 1994-09-09 1996-03-26 Morinaga Milk Ind Co Ltd 創傷治癒剤
US5690961A (en) 1994-12-22 1997-11-25 Hercules Incorporated Acidic polysaccharides crosslinked with polycarboxylic acids and their uses
DE69634823T2 (de) 1995-08-29 2006-03-23 Fidia Advanced Biopolymers S.R.L. Aus hyaluronsäurederivaten bestehenden biomaterialien zur hemmung der postoperativen adhäsionsbildung
US6037331A (en) 1996-07-19 2000-03-14 Poly-Med, Inc. Compositions for prevention of inflammation and adhesion formation uses thereof
US6515016B2 (en) * 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis
JP2002519332A (ja) * 1998-06-26 2002-07-02 エヌ・ヴェー・ニュートリシア 微生物によって引き起こされる表面感染症の治療または予防に使用するための医薬調製物
SE9804614A0 (en) * 1998-07-06 2000-01-07 A+ Science Invest Ab New peptides and use thereof
US7218503B2 (en) 1998-09-30 2007-05-15 Lam Research Corporation Method of determining the correct average bias compensation voltage during a plasma process
US6521223B1 (en) 2000-02-14 2003-02-18 Genzyme Corporation Single phase gels for the prevention of adhesions
CA2416126C (en) 2000-07-28 2011-07-05 Anika Therapeutics, Inc. Bioabsorbable composites of derivatized hyaluronic acid
KR100375299B1 (ko) 2000-10-10 2003-03-10 주식회사 엘지생명과학 히알루론산의 가교결합형 아마이드 유도체와 이의 제조방법
WO2002044276A2 (en) 2000-11-28 2002-06-06 Focal, Inc. Polyalkylene glycol viscosity-enhancing polymeric formulations
EP1284143A1 (en) 2001-08-17 2003-02-19 Sifi S.p.A A process for the preparation of pharmaceutical formulations containing lactoferrin description
SE0200667D0 (sv) * 2002-03-05 2002-03-05 A & Science Invest Ab Novel use of cytokine inhibitors
KR100523953B1 (ko) 2002-08-27 2005-10-25 주식회사 엘지생명과학 천연다당류와 히알루론산의 마이크로비드 및 이의 제조 방법
AU2004270815B2 (en) 2003-09-11 2011-06-02 Novozymes Adenium Biotech A/S Recombinant production of antimicrobial agents
KR101244519B1 (ko) 2004-03-17 2013-03-18 젠자임 코포레이션 항점착 분무
ITPD20040245A1 (it) 2004-10-08 2005-01-08 Fidia Advanced Biopolymers Srl Biomateriali costituiti da acido ialuronico solfatato e gellano utilizzabili nella prevenzione delle adesioni spinali
WO2006047744A2 (en) * 2004-10-26 2006-05-04 Agennix Incorporated Compositions of lactoferrin related peptides and uses thereof
EP1919500A2 (en) * 2005-07-13 2008-05-14 Anthrogenesis Corporation Treatment of leg ulcers using placenta derived collagen biofabric
EP2050461A1 (en) * 2007-10-19 2009-04-22 PharmaSurgics in Sweden AB Peptides based on the sequence of human lactoferrin and their use
RU2501566C2 (ru) 2009-01-13 2013-12-20 Пергамум АБ Новые фармацевтические композиции

Also Published As

Publication number Publication date
AU2010205751B2 (en) 2013-05-02
US20200188490A1 (en) 2020-06-18
US20110306565A1 (en) 2011-12-15
BRPI1006076B1 (pt) 2020-10-06
US20140349949A1 (en) 2014-11-27
EP2387390A2 (en) 2011-11-23
KR20110114610A (ko) 2011-10-19
CA2748860C (en) 2014-09-23
CA2748860A1 (en) 2010-07-22
RU2011133224A (ru) 2013-02-20
WO2010081800A2 (en) 2010-07-22
KR101406743B1 (ko) 2014-06-20
BRPI1006076A2 (pt) 2016-04-19
EP2387390B1 (en) 2012-11-28
ES2400466T3 (es) 2013-04-10
JP5646507B2 (ja) 2014-12-24
US10471129B2 (en) 2019-11-12
US11000574B2 (en) 2021-05-11
CN102271658B (zh) 2013-06-12
US9878019B2 (en) 2018-01-30
CN102271658A (zh) 2011-12-07
PL2387390T3 (pl) 2013-12-31
HK1164701A1 (en) 2012-09-28
WO2010081800A3 (en) 2010-11-25
US20180200341A1 (en) 2018-07-19
BRPI1006076B8 (pt) 2021-05-25
ZA201105806B (en) 2012-04-25
RU2501566C2 (ru) 2013-12-20
JP2012515151A (ja) 2012-07-05
AU2010205751A1 (en) 2011-07-28

Similar Documents

Publication Publication Date Title
EA201490521A1 (ru) Варианты фактора роста фибробластов 21
WO2017044894A3 (en) Cartilage-homing peptides
IN2012DN00971A (es)
EA201492053A1 (ru) Белки фактора роста фибробластов 21
MY167691A (en) A pharmaceutical spray composition comprising a vitamin d analogue and a corticosteroid
EA201492064A1 (ru) Варианты фактора роста фибробластов 21
EP2444491A3 (en) Hyperglycosylated human coagulation factor IX
MX2011007462A (es) Composiciones que contienen acido hialuronico para el tratamiento de heridas, cicatrices, formacion de dahesiones postquirurgicas.
UA105036C2 (uk) Амінотетралінові похідні, фармацевтична композиція, яка їх містить, і їх застосування в терапії
MY158325A (en) Multitype peptide compositions and methods for treatment or prevention of human papillpmavirus infection
MX350046B (es) Tratamientos para trastornos gastrointestinales.
WO2010085039A2 (ko) 노긴―유래 펩타이드 및 그의 용도
GB2492935A (en) Conjugated blood coagulation factor VIII
GB201001602D0 (en) Oligopeptidic compounds and uses therof
MX2012013606A (es) Polisacarido de semillas de tamarindo para usarse en el tratamiento de infecciones microbianas.
MX2012006430A (es) Preparaciones de combinacion que comprenden un antagonista de citocina y un corticosteroide.
WO2015157469A3 (en) Polypeptide compositions with type vii collagen fibronectin type iii- like repeats and treatment methods for wound closure and healing
EA201270116A1 (ru) Применение лекарственной формы для наружного нанесения, содержащей хитозан
MX2013007995A (es) Peptidos derivados de lactoferrina humana y su uso.
EA201200428A1 (ru) Композиция и способ для лечения ожирения
GEP201606514B (en) Apoptosis inhibitors and usage thereof
TR201004464A2 (tr) Kemik erimesi için formülasyon.
MX2012013607A (es) Polisacarido de las semillas de tamarindo para usarse en el tatamiento de enfermedades inflamatorias.
MX336278B (es) Composiciones y metodos para la prevencion y el tratamiento de heridas.
WO2014039074A3 (en) Therapeutic compositions and related methods

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: PERGAMUM AB

FG Grant or registration